Viewing SEC Facts Units
Company Name:
Stoke Therapeutics, Inc.
CIK:
1623526
Start Filing Date:
2023-07-01
End Filing Date:
2023-09-30
ACCN:
0000950170-23-060224
Value:
$ 10,936,000
Value Error:
$ None
Created By:
Date Filed:
2023-11-07
FY:
2023
Fiscal Period:
Q3
Frame:
CY2023Q3I
Type:
us-gaap
Form:
10-Q
Units:
USD